Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 13, 2019 Off

Diabetic Foot Ulcers Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Foot Ulcers Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Diabetic…

June 13, 2019 Off

Terns Pharmaceuticals Initiates a Phase 1 Clinical Trial of TERN-101

By BusinessWire

Phase 1 study will evaluate the safety and tolerability of TERN-101, an FXR agonist in development for the treatment of…

June 13, 2019 Off

Chronic Myeloid Leukemia Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Chronic Myeloid Leukemia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Chronic…

June 13, 2019 Off

2019 Breast Cancer Clinical Trial Pipeline Highlights Report – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Breast Cancer Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Breast Cancer…

June 13, 2019 Off

Three Day Advanced Pharmacovigilance Course (London, United Kingdom – September 25-27, 2019) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance” conference has been added to ResearchAndMarkets.com’s offering. This course will be of maximum benefit to those…

June 13, 2019 Off

Servier announces European Commission decision to convert conditional approval into standard marketing authorization in patients with aggressive non-Hodgkin B-cell lymphoma for PIXUVRI® (pixantrone)

By BusinessWire

Pixantrone has been available to patients since 2012 following a conditional approval in Europe PARIS–(BUSINESS WIRE)–Servier today announced that the…

June 13, 2019 Off

Phase III PEMPHIX Study Showed That Genentech’s Rituxan (Rituximab) is Superior to Standard of Care in Achieving Sustained Remission in Patients with Pemphigus Vulgaris

By BusinessWire

Rituxan met the primary and secondary endpoints in the Phase III PEMPHIX study Rituxan was the first and only biologic…

June 13, 2019 Off

BioCell Technology Announces BioCell Collagen® Skin Aging Clinical Trial Poster Presentation at ASN Nutrition 2019

By BusinessWire

Dietary supplementation with BioCell Collagen® significantly reduced facial lines and wrinkles, crow’s feet lines/wrinkles, increased skin elasticity and cutaneous collagen…

June 12, 2019 Off

Tetraphase Pharmaceuticals Announces Corporate Reorganization Aimed at Maximizing XERAVA™ (Eravacycline) Commercial Opportunity

By BusinessWire

Company to Eliminate Internal Research Function and Explore Pipeline Out-licensing Opportunities to Focus the Company’s Resources on XERAVA™ Commercial Success…

June 12, 2019 Off

Applied BioCode Obtains FDA Clearance of the Roche MagNA Pure 96 Extraction System for its Gastrointestinal Pathogen Panel

By BusinessWire

SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–Applied BioCode announced today that it has received U.S. Food and Drug Administration 510(k) clearance for…

Posts pagination

Previous 1 … 3,099 3,100 3,101 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine